Sign Up to like & get
recommendations!
1
Published in 2022 at "Genes"
DOI: 10.1002/gcc.23075
Abstract: Mesenchymal chondrosarcoma (MCS) is a rare translocation‐associated sarcoma, driven by a canonical HEY1::NCOA2 fusion. The tumors typically have a biphasic phenotype of primitive small blue round cells intermixed with hyaline cartilage. The head and neck…
read more here.
Keywords:
head neck;
mesenchymal chondrosarcoma;
ncoa2 fusion;
chondrosarcoma head ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Histopathology"
DOI: 10.1111/his.14364
Abstract: A previously healthy 12-year-old boy began experiencing intracranial hypertension symptoms. Cerebral magnetic resonance imaging (MRI) showed a pineal mass. Cerebrospinal fluid and blood tested negative for β-human chorionic gonadotrophin, α-foetoprotein, carcinoembryonic antigen, and placental alkaline…
read more here.
Keywords:
fusion inducing;
pax3 ncoa2;
ncoa2 fusion;
rhabdomyosarcoma pax3 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.am2024-3359
Abstract: Mesenchymal chondrosarcoma (MCS) is a rare high-grade mesenchymal neoplasm occurring in bone and soft tissue. It accounts for 2%~10% of all chondrosarcomas and affects mainly adolescents and young adults. Genetically, this tumor is characterized by…
read more here.
Keywords:
differentiation;
chondrogenic differentiation;
hey1 ncoa2;
ncoa2 fusion ... See more keywords